Results 81 to 90 of about 1,241,346 (218)

SIMULATION OF A REDUCED RED BLOOD CELL SHELF LIFE

, 2015
Since the 1970’s, red blood cells have had a rated shelf life of 42 days. Recently, questions have been raised regarding the safety of transfusing "older" red blood cells.
Hardy, Matthew
core  

Microvesicles in disease [PDF]

, 2014
On activation cells shed vesicles from their surface by the process of ectocytosis. These micro-vesicles or Ectosomes express phosphatidyl-serine (PS) on their surface, which can elicit a range of biological effects from immune-suppression to the ...
Čumpelik, Arun
core   +1 more source

Particle based modeling and simulation of the red blood cell Infected by malaria-mechanism of the margination of the Infected red blood cell

, 2011
This paper was presented at the 3rd Micro and Nano Flows Conference (MNF2011), which was held at the Makedonia Palace Hotel, Thessaloniki in Greece.
Ishikawa, T, Imai, Y, Yamaguchi, T, 3rd Micro and Nano Flows Conference (MNF2011)   +3 more
core  

Allogeneic Umbilical Cord Blood Red Cell Concentrates: An Innovative Blood Product for Transfusion Therapy of Preterm Infants

, 2014
Background: Preterm infants often receive blood transfusions early in life. In this setting, umbilical cord blood (UCB) might be safer than adult blood (A) with respect to infectious and immunologic threats. Objectives: To evaluate, as a first objective,
Fioretti, Maria, Teofili, Luciana, Valentini, Caterina Giovanna, Romagnoli, Costantino, Spartano, Serena, Tesfagabir, Mikael Ghennet, Vento, Giovanni, Tornesello, Assunta, Landini, Alessandra, Papacci, Patrizia, Bianchi, Maria, Giannantonio, Carmen, Molisso, Anna, Zini, Gina   +13 more
core   +1 more source

Flow field characterisation of aggregating human blood in bifurcating microchannels

, 2011
This paper was presented at the 3rd Micro and Nano Flows Conference (MNF2011), which was held at the Makedonia Palace Hotel, Thessaloniki in Greece.
Balabani, S, Sherwood, JM, Kaliviotis, E, Dusting, J, 3rd Micro and Nano Flows Conference (MNF2011)   +4 more
core  

PB2509: RED BLOOD CELL PYRUVATE KINASE PROPERTIES IN SICKLE CELL DISEASE – OF MICE AND MEN

HemaSphere, 2023
Marissa Traets, Brigitte van Oirschot, Charles Levine, Judith Jans, Minke Rab, Yu-Wei Chen, Richard Van Wijk   +6 more
doaj   +1 more source

Dynamics of neutrophil phenotype and function in sickle cell disease

Frontiers in Immunology
IntroductionWhile sickle cell disease (SCD) is primarily acknowledged as an erythrocyte disorder, emerging evidence suggests a role for altered neutrophil phenotype and function in SCD pathophysiology and disease severity.
Aafke E. Gaartman, Aafke E. Gaartman, Lydian A. de Ligt, Lydian A. de Ligt, Lydian A. de Ligt, Boukje M. Beuger, Anton T. J. Tool, Martijn Veldthuis, Taco W. Kuijpers, Taco W. Kuijpers, Rob van Zwieten, Bart J. Biemond, Robin van Bruggen, Erfan Nur, Erfan Nur   +14 more
doaj   +1 more source

Erythrocytes lacking the Langereis blood group protein ABCB6 are resistant to the malaria parasite Plasmodium falciparum

Communications Biology, 2018
Elizabeth Egan and colleagues demonstrate that host ATP binding cassette transporter ABCB6, which encodes the Langereis blood group antigen, promotes erythrocyte invasion by the malaria parasite Plasmodium falciparum.
Elizabeth S. Egan, Michael P. Weekes, Usheer Kanjee, Jale Manzo, Ashwin Srinivasan, Christine Lomas-Francis, Connie Westhoff, Junko Takahashi, Mitsunobu Tanaka, Seishi Watanabe, Carlo Brugnara, Steven P. Gygi, Yoshihiko Tani, Manoj T. Duraisingh   +13 more
doaj   +1 more source

P717: AG946, A PYRUVATE KINASE (PK) ACTIVATOR IMPROVES PK PROPERTIES AND RED BLOOD CELL (RBC) METABOLISM UPON EX VIVO TREATMENT OF RBCS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROMES

HemaSphere, 2023
Jonathan de Wilde, Titine Ruiter, Brigitte van Oirschot, Judith Jans, Lenny Dang, Megan Wind-Rotolo, Wouter van Solinge, Anna van Rhenen, Richard Van Wijk, Minke Rab   +9 more
doaj   +1 more source

Low-dose cyclophosphamide combined with standard immunosuppressive therapy improves early response rates in severe aplastic anemia

Frontiers in Immunology
BackgroundThrombopoietin receptor agonists combined with anti-thymocyte globulin (ATG) and cyclosporine (CsA) are the standard immunosuppressive therapy (IST) for severe/very severe aplastic anemia (SAA/VSAA).
Hong Pan, Hong Pan, Hong Pan, Zhen Gao, Zhen Gao, Zhen Gao, Lele Zhang, Lele Zhang, Lele Zhang, Weiwang Li, Weiwang Li, Weiwang Li, Ruonan Li, Ruonan Li, Ruonan Li, Jingyu Zhao, Jingyu Zhao, Jingyu Zhao, Xiao Yu, Xiao Yu, Xiao Yu, Zhexiang Kuang, Zhexiang Kuang, Zhexiang Kuang, Neng Nie, Neng Nie, Neng Nie, Jianping Li, Jianping Li, Jianping Li, Yuan Li, Yuan Li, Yuan Li, Xingxin Li, Xingxin Li, Xingxin Li, Jinbo Huang, Jinbo Huang, Jinbo Huang, Xin Zhao, Xin Zhao, Xin Zhao, Jing Zhang, Jing Zhang, Jing Zhang, Meili Ge, Meili Ge, Meili Ge, Yizhou Zheng, Yizhou Zheng, Yizhou Zheng, Liwei Fang, Liwei Fang, Liwei Fang, Jun Shi, Jun Shi, Jun Shi   +56 more
doaj   +1 more source